Evidence map›Paper›PMID 29717334›Full record

ArticlePsychopharmacology2018

The role of striatal dopamine D

Tanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, Paul Cumming, Michael Paulzen, Felix M Mottaghy, Gerhard Gründer

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Expression of Dopamine DFrontiers in psychiatry · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Tanja VeselinovićDepartment of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany. tveselinovic@ukaachen.de.ORCID http://orcid.org/0000-0001-7906-6966
Ingo VernalekenDepartment of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Hildegard JanouschekDepartment of Psychiatry and Iowa Neuroscience Institute, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Paul CummingSchool of Psychology and Counselling and IHBI, Queensland University of Technology, and QIMR-Berghofer Institute, Brisbane, Australia.
Michael PaulzenDepartment of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Felix M MottaghyDepartment of Nuclear Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Gerhard GründerDepartment of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Jülich Aachen Research Alliance · DEHeidelberg University · DEMaastricht University · NLQueensland University of Technology · AUUniversitätsklinikum Aachen · DEUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA considerable body of research links cognitive function to dopaminergic transmission in the prefrontal cortex, but less is known about cognition in relation to striatal dopamine D

methodsWe investigated this association by obtaining PET recordings with the high-affinity D

resultsThe patients' performance in cognitive tests was significantly impaired in almost all domains. Irrespective of medication history, the mean [ DISCUSSION: The association between better cognitive performance and greater BP

Indexed as

AdolescentAdultBenzamidesBrain MappingCognitionCorpus StriatumDopamine D2 Receptor AntagonistsFemaleHumansMaleMiddle AgedNeuropsychological TestsPositron-Emission TomographyReceptors, Dopamine D2Receptors, Dopamine D3SchizophreniaBenzamidesDopamine D2 Receptor AntagonistsfallyprideReceptors, Dopamine D2Receptors, Dopamine D3Cognitive impairmentsDopamine D2/3 receptorsSchizophreniaStriatum

Identifiers

PMID29717334
OpenAlexW2800790236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.